Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Blanchard Cheryl R	2. Issuer Name and Ticker or Trading Symbol Anika Therapeutics, Inc. [ ANIK ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) President, CEO, Director
(Last)          (First)          (Middle) 32 WIGGINS AVENUE	3. Date of Earliest Transaction (MM/DD/YYYY) 4/26/2020
(Street) BEDFORD, MA 01730 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (1)	4/26/2020		M		4231	A	$0	11697	D
Common Stock (2)	4/26/2020		F		1794	D	$33.40 (3)	9903	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.00	4/26/2020		A		73726		(4)	(4)	Common Stock	73726	$0	73726	D
Stock Option (Right to Buy)	$33.40	4/26/2020		A		104638		(5)	4/26/2030	Common Stock	104638	$0	104638	D

Explanation of Responses:
(1)	Reflects the vesting of RSUs granted on February 25, 2020 in accordance with the terms of Dr. Blanchard's agreement with the Company related to her appointment as its interim Chief Executive Officer.
(2)	Reflects an aggregate of 1,794 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on April 26, 2020.
(3)	Reflects the closing price of the ANIK common stock on April 26, 2020, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
(4)	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning April 26, 2021.
(5)	The stock options vest in three equal annual installments beginning April 26, 2021.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Blanchard Cheryl R 32 WIGGINS AVENUE BEDFORD, MA 01730	X		President, CEO, Director

Signatures
/s/ Cheryl R. Blanchard		4/28/2020
**Signature of Reporting Person		Date